Innate Pharma's Series A Round

Innate Pharma raised a round of funding on January 01, 2000.

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or ind…

Articles about Innate Pharma's Series A Round: